ACUTE RHINITIS: NEW THERAPEUTIC POSSIBILITIES

According to the World Health Organization pathology of the respiratory system ranks first (in some countries, second) in the structure of morbidity of the population worldwide. The complexity of the treatment, and growth of the unreasonable prescription of many drugs, leading to increased problems of polypragmasie, antibioticoresistance, allergization of the population, etc., encourages physicians to reconsider the boundaries of drug therapy and persistently look for new opportunities for effective and safe therapy. An open multicentre study was conduced to assess the effectiveness and tolerability of Coryzalia® in the treatment of acute infectious rhinitis, that showed that the complex homeopathic drug quickly relieves the main symptoms of acute infectious rhinitis on the background of SARS. By the 3rd day of therapy such symptoms as headache, rhinorrhea, nasal obstruction, sneezingare reduced twice.